Dow Down 0.49% Nasdaq Up 0.37%

Cytokinetics, Incorporated (CYTK)

-NasdaqCM
3.38 Up 0.12(3.83%) 10:12AM EDT - Nasdaq Real Time Price
Prev Close:3.26
Open:3.28
Bid:3.29 x 100
Ask:3.31 x 1100
1y Target Est:10.80
Beta:1.3
Next Earnings Date:30-Oct-14CYTK Earnings announcement
Day's Range:3.27 - 3.38
52wk Range:3.05 - 13.26
Volume:29,440
Avg Vol (3m):408,958
Market Cap:123.91M
P/E (ttm):N/A
EPS (ttm):-0.72
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTK

Comparison

Symbol% ChgMkt Cap
CYTKUp 3.83%123.91M
BIIBUp 0.61%72.87B
LGNDUp 1.32%1.05B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.68
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.99
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-0.23

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytokinetics, Incorporated, a clinical stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditi... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback